Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Posocco

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|May 28, 2020
A LC-MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinomaValentina Iacuzzi, Martina Zanchetta, Sara Gagno, et al.
Therapeutic Drug Monitoring|February 17, 2024
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS MethodBianca Posocco, Martina Zanchetta, Marco Orleni, et al.
Frontiers in Immunology|October 24, 2024
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case seriesSara Gagno, Bianca Posocco, Marco Orleni, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2022
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mgYi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 22, 2025
Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devicesMarco Orleni, Sara Gagno, Eleonora Cecchin, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failureSara Gagno, Angela Buonadonna, Chiara Dalle Fratte, et al.
Frontiers in Pharmacology|September 23, 2024
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactionsElena Peruzzi, Bianca Posocco, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences|October 16, 2024
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug MonitoringEleonora Cecchin, Marco Orleni, Sara Gagno, et al.
Chemical Communications (Cambridge, England)|September 17, 2013
Light driven water oxidation by a single site cobalt salophen catalystErica Pizzolato, Mirco Natali, Bianca Posocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2016
Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal CancerGiuseppe Toffoli, Manish R Sharma, Elena Marangon, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pharmaceutical and Biomedical Analysis|May 28, 2020
A LC-MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinomaValentina Iacuzzi, Martina Zanchetta, Sara Gagno, et al.
Therapeutic Drug Monitoring|February 17, 2024
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS MethodBianca Posocco, Martina Zanchetta, Marco Orleni, et al.
Frontiers in Immunology|October 24, 2024
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case seriesSara Gagno, Bianca Posocco, Marco Orleni, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2022
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mgYi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 22, 2025
Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devicesMarco Orleni, Sara Gagno, Eleonora Cecchin, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|June 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failureSara Gagno, Angela Buonadonna, Chiara Dalle Fratte, et al.
Frontiers in Pharmacology|September 23, 2024
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactionsElena Peruzzi, Bianca Posocco, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences|October 16, 2024
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug MonitoringEleonora Cecchin, Marco Orleni, Sara Gagno, et al.
Chemical Communications (Cambridge, England)|September 17, 2013
Light driven water oxidation by a single site cobalt salophen catalystErica Pizzolato, Mirco Natali, Bianca Posocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2016
Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal CancerGiuseppe Toffoli, Manish R Sharma, Elena Marangon, et al.
Pageof 5